Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.39)
# 2,504
Out of 5,154 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $49 → $47 | $44.55 | +5.70% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $115.07 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $174.00 | +342.53% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $36.68 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $77.60 | -12.37% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $12.74 | +418.05% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $124.62 | +131.10% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $501.97 | -48.20% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $302.54 | -30.26% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $5.15 | +948.54% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $198.13 | -79.31% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $269.85 | +24.14% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $278.21 | +20.41% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $49 → $47
Current: $44.55
Upside: +5.70%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $115.07
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $174.00
Upside: +342.53%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $36.68
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $77.60
Upside: -12.37%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $12.74
Upside: +418.05%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $124.62
Upside: +131.10%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $501.97
Upside: -48.20%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $302.54
Upside: -30.26%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $5.15
Upside: +948.54%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $198.13
Upside: -79.31%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $269.85
Upside: +24.14%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $278.21
Upside: +20.41%